![]() |
![]() |
Legal status
Patent in force
(51) | INT.CL. | A61K 31/519 | (2006.01) |
A61K 31/506 | (2006.01) | ||
A61P 35/00 | (2006.01) |
(11) | Number of the document | 2892535 |
(13) | Kind of document | T |
(96) | European patent application number | 13835019.4 |
Date of filing the European patent application | 2013-08-30 | |
(97) | Date of publication of the European application | 2015-07-15 |
(45) | Date of publication and mention of the grant of the patent | 2021-09-22 |
(46) | Date of publication of the claims translation | 2021-12-10 |
(86) | Number | PCT/US2013/057432 |
Date | 2013-08-30 |
(87) | Number | WO 2014/039375 |
Date | 2014-03-13 |
(30) | Number | Date | Country code |
201261696375 P | 2012-09-04 | US |
(72) |
LAQUERRE, Sylvie , US
LEBOWITZ, Peter F. , US
|
(73) |
Novartis AG ,
Lichtstrasse 35, 4056 Basel,
CH
|
(74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
(54) | Adjuvantinis vėžio gydymo būdas |
METHOD OF ADJUVANT CANCER TREATMENT |
Payment date | Validity (years) | Amount | |
2025-07-23 | 13 | 289.00 EUR |
2026-08-30 |